Arab Pharmaceuticals

مادة اعلانية

Latest Update: 15 May 2025 15:12 Abu Dhabi Time.

Market Status: Closed

ADCI

Arab Pharmaceuticals

172.52

EGP

-7.270

-4.04%

Open

179.79

Prev Close

179.79

PX_VOLUME

3,002

MARKET CAP (M)

DAY RANGE

172.10 - 177.40

52 WEEKS

76.02 - 186.50

Stock Statistics

Yearly Change

83.51%

Listed Shares (Million)

6.00

Earnings Multiple

7.25

Average 30-day trading volume

2,735.05

Price-to-book ratio

2.07

Earnings Per Share

17.14

Previous Dividend Distribution

7.93

Dividend Yield

4.83%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		324.80	233.33	204.44	167.19	222.66	191.24
Gross Profit		142.60	94.63	68.62	44.23	87.45	65.69
Operating Income		95.80	48.16	23.44	10.37	45.64	33.77
Profit Margin		21.46	15.56	9.94	10.06	17.19	14.34

	Period Ending:	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		785.52	633.73	505.04	537.05
Gross Profit		265.99	224.35	185.43	230.30
Operating Income		118.10	94.76	89.82	122.16
Profit Margin		13.09	13.06	15.11	18.88

Balance Sheet

	Period Ending:	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,215.16	1,198.23	1,133.59	1,100.14	1,057.19	732.60
Total Liabilities		713.65	766.75	675.06	657.93	645.23	321.95
Total Equity		501.51	431.48	458.53	442.21	411.96	410.65

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.